Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 707

1.
2.

Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.

Waters D, Danska J, Hardy K, Koster F, Qualls C, Nickell D, Nightingale S, Gesundheit N, Watson D, Schade D.

Ann Intern Med. 1996 Dec 1;125(11):865-72.

PMID:
8967666
3.

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

Schambelan M, Mulligan K, Grunfeld C, Daar ES, LaMarca A, Kotler DP, Wang J, Bozzette SA, Breitmeyer JB.

Ann Intern Med. 1996 Dec 1;125(11):873-82.

PMID:
8967667
4.

Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy.

Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E; Serono 9037 Study Team.

J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):367-75.

PMID:
15097153
5.
6.

Efficacy of selected treatments of HIV wasting: a systematic review and meta-analysis.

Moyle GJ, Schoelles K, Fahrbach K, Frame D, James K, Scheye R, Cure-Bolt N.

J Acquir Immune Defic Syndr. 2004 Dec 1;37 Suppl 5:S262-76. Review.

PMID:
15722869
7.

Short-term growth hormone administration at the time of opportunistic infections in HIV-positive patients.

Paton NI, Newton PJ, Sharpstone DR, Ross HM, Cotton J, Calder AG, Milne E, Elia M, Shah S, Engrand P, Macallan DC, Gazzard BG, Griffin GE.

AIDS. 1999 Jul 9;13(10):1195-202.

PMID:
10416522
8.

Somatropin (mammalian cell-derived recombinant human growth hormone) for HIV-associated wasting.

MacDougall DS.

J Int Assoc Physicians AIDS Care. 1997 Oct;3(10):30-5.

PMID:
11364744
9.

Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART.

Evans WJ, Kotler DP, Staszewski S, Griffin GE, Isgaard J, Gertner JM, O'Brien F, Svanberg E.

AIDS Read. 2005 Jun;15(6):301-3, 306-8, 310, 314.

PMID:
15962453
10.

Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.

Hengge UR, Stocks K, Wiehler H, Faulkner S, Esser S, Lorenz C, Jentzen W, Hengge D, Goos M, Dudley RE, Ringham G.

AIDS. 2003 Mar 28;17(5):699-710.

PMID:
12646793
11.

Use of growth hormone and other anabolic agents in AIDS wasting.

Mulligan K, Tai VW, Schambelan M.

JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6 Suppl):S202-9. Review.

PMID:
10571456
12.

Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting.

Esposito JG, Thomas SG, Kingdon L, Ezzat S.

Am J Physiol Endocrinol Metab. 2005 Sep;289(3):E494-503. Epub 2005 May 10.

13.

Recombinant human growth hormone for AIDS-associated wasting.

Windisch PA, Papatheofanis FJ, Matuszewski KA.

Ann Pharmacother. 1998 Apr;32(4):437-45. Review.

PMID:
9562140
14.

Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients.

Nguyen BY, Clerici M, Venzon DJ, Bauza S, Murphy WJ, Longo DL, Baseler M, Gesundheit N, Broder S, Shearer G, Yarchoan R.

AIDS. 1998 May 28;12(8):895-904.

PMID:
9631143
16.

[The use of growth hormone to treat endocrine-metabolic disturbances in acquired immunodeficiency syndrome (AIDS) patients].

Spinola-Castro AM, Siviero-Miachon AA, da Silva MT, Guerra-Junior G.

Arq Bras Endocrinol Metabol. 2008 Jul;52(5):818-32. Review. Portuguese.

17.

HIV-related wasting in HIV-infected drug users in the era of highly active antiretroviral therapy.

Campa A, Yang Z, Lai S, Xue L, Phillips JC, Sales S, Page JB, Baum MK.

Clin Infect Dis. 2005 Oct 15;41(8):1179-85. Epub 2005 Aug 30.

18.

Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men.

Roubenoff R, Grinspoon S, Skolnik PR, Tchetgen E, Abad L, Spiegelman D, Knox T, Gorbach S.

Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E138-45.

19.

Sustained low-dose growth hormone therapy optimizes bioactive insulin-like growth factor-I level and may enhance CD4 T-cell number in HIV infection.

Andersen O, Hansen BR, Troensegaard W, Flyvbjerg A, Madsbad S, ├śrskov H, Nielsen JO, Iversen J, Haugaard SB.

J Med Virol. 2010 Feb;82(2):197-205. doi: 10.1002/jmv.21625.

PMID:
20029798
20.

Diabetes mellitus associated with recombinant human growth hormone for HIV wasting syndrome.

Schauster AC, Geletko SM, Mikolich DJ.

Pharmacotherapy. 2000 Sep;20(9):1129-34.

PMID:
10999508
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk